Premier Value by is a Otc medication manufactured, distributed, or labeled by Chain Drug Consortium, Taro Pharmaceuticals U.S.A., Inc., Taro Pharmaceuticals Inc.. Drug facts, warnings, and ingredients follow.
| PREMIER VALUE
TRIPLE ANTIBIOTIC
bacitracin zinc, neomycin sulfate, and polymyxin b sulfate ointment |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - Chain Drug Consortium (101668460) |
| Registrant - Taro Pharmaceuticals U.S.A., Inc. (145186370) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
|---|---|---|---|
| Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE(68016-500) | |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PREMIER VALUE 78208206 3357001 Live/Registered |
PHARMACY VALUE ALLIANCE, LLC 2003-01-29 |
![]() PREMIER VALUE 75164203 2113837 Dead/Cancelled |
MINNESOTA FIRE AND CASUALTY COMPANY 1996-09-11 |